Skip to content

Cerebellum - Cognitive Outcome and Functional Connectivity

Cerebellar Tumors of Childhood - Impact on Cognition and Functional Connectivity

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01730274
Enrollment
31
Registered
2012-11-21
Start date
2013-01-31
Completion date
2015-02-28
Last updated
2021-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cerebellar Tumor

Brief summary

Aim: To investigate the effect of cerebellar tumor surgery on the resting state functional connectivity level in higher order cognition networks known to interact with the cerebellum. Furthermore, to correlate the connectivity level of these networks with the neuropsychological performance and functional outcome of the patients. The investigator's hypothesis is that the functional connectivity of various cognition networks in the cerebrum as assessed by resting-state functional magnetic resonance imaging can be impaired after cerebellar tumor surgery and can be correlated with the neuropsychological performance. The effect of surgery on the cognition networks and the neuropsychological performance is dependent on the tumor location within the cerebellum. Such a correlation seems feasible as functional connectivity analysis could be correlated with the neuropsychological impairment in various neuropsychiatric disorders. Furthermore, investigators were able to depict the maturation of the functional connectivity networks in parallel to the neurocognitive development in childhood

Interventions

None listed

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* • Male or female patients aged \> 15 yrs * Age at surgery between 1 yrs - 12 yrs * Compliance (the patients have to be able to lay motionless in a 3 Tesla MR scanner and to cooperate with the examiner during the examination) * Signed informed consent from the patient and/or the parents

Exclusion criteria

* • Patients with Neurofibromatosis 1 * Severe visual or auditory impairment * Cerebrospinal fluid shunt device * Prior radiotherapy or chemotherapy * Contraindications to MRI

Design outcomes

Primary

MeasureTime frame
neuropsychological assessmentup to 24 months

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026